Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers

NCT07213089 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Pertussis Whooping Cough

Interventions

BIOLOGICAL: Combined Diphtheria-Tetanus-recombinant acellular pertussis (DTaP) vaccine
BIOLOGICAL: Licensed DTaP

Sponsor

BioNet-Asia Co., Ltd.

Collaborators

[object Object]
[object Object]